This, in turn, supports tumor survival, chemoresistance, and invasiveness through pathways such as the AKT 10, CCL2 11, and Wnt/β-catenin signaling pathways 12, making Hsp47 a potential prognostic biomarker and therapeutic target for CRC patients. Here, SERPINH1 is linked to neoplasm.